Montreal-based Dialogue has acquired DXA, an AI tool meant to replicate how an ER doctor’s brain thinks.
“We built a platform that can evaluate a patient and output a comprehensive medical note,” said Dr. Jonah Hebert-Davies, co-founder of DXA. Hebert-Davies also works as an orthopedic trauma surgeon at Harborview Medical Center of the University of Washington in Seattle.
Hebert-Davies added that patients can be evaluated in the language of their choice, and the medical history is outputted to the provider in English or French. “This platform can be used by telehealth, ER, and clinic providers to automate triage and the clinical chart note all while improving the patient’s journey throughout their care. It can even be integrated to most electronic medical records and can also be a very helpful health risk evaluation tool for insurance carriers.”
The DXA team will join Dialogue, and the DXA technology has already been integrated into Dialogue’s platform, which allows the employers to offer employees access to healthcare services through their phone. Dialogue said partnership discussions are ongoing with potential partners in Canada and abroad.
“This technology has the potential to revolutionize how people access healthcare and will generate substantial efficiencies for healthcare providers,” said Cherif Habib, co-founder and CEO of Dialogue. “It complements our virtual care platform and will allow Dialogue to equip hospitals, clinics and insurers with a cutting-edge technology that can significantly increase efficiency and accuracy while also reducing costs. We plan to invest substantially in artificial intelligence and build on this technology while also keeping our “human-in-the-loop” approach and continue offering the best and safest care possible to our clients and users.”